Drug intelligence / Profile preview

Sunpharma1505

Development stage: Unknown
Lead developer: Sun Pharma

Overview

Sunpharma1505 is a code name for a drug evaluated by Sun Pharmaceutical Industries Limited in clinical trials for the treatment of active rheumatoid arthritis. The available evidence suggests that it is being compared to "Reference1505" in at least one clinical study, but no further details about its chemical structure, mechanism of action, or active ingredient are provided in public sources. There is insufficient information to determine whether Sunpharma1505 corresponds to any known small molecule or biologic agent, nor are there published data on its pharmacological class or molecular target[1]. The developer and likely manufacturer is Sun Pharmaceutical Industries Limited.

Beyond the preview

Go deeper on Sunpharma1505.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sunpharma1505.

Explore the full profile